AbstractViral Hepatitis and Liver DiseaseCOLDA 2020_abstract_79_Aspects psychosociaux de la vie des patients souffrants de l’hépatite virale en Guinée, à propos de 2739 casView Abstract
AbstractViral Hepatitis and Liver DiseaseCOLDA_2020_abstract_2_Fibroscan findings in patients with chronic liver diseases in RwandaView Abstract
AbstractViral Hepatitis and Liver DiseaseCOLDA_2020_abstract_1_Assessment of non-invasive markers of liver fibrosis in patients with chronic hepatitis C in EthiopiaView Abstract
AbstractViral Hepatitis and Liver DiseaseCOLDA_2020_abstract_3_Evaluation de la détection de l’AgHBe pour l’identification des charges virales élevées du virus de l’hépatite B exposant au risque de transmission mère enfant malgré la vaccination à la naissanceView Abstract
AbstractViral Hepatitis and Liver DiseaseCOLDA_2020_abstract_5_Experience of the first hepatitis B program in rural Sierra Leone: one year of successes and challengesView Abstract
AbstractViral Hepatitis and Liver DiseaseCOLDA_2020_abstract_6_Frequency of Occult Hepatitis B Virus among blood Donors in Khartoum State, Sudan: a preliminary study.View Abstract
AbstractViral Hepatitis and Liver DiseaseCOLDA_2020_abstract_4_Résistance du VHB aux inhibiteurs nucléo(s)tidiques de la transcriptase inverse (INTI) et son impact sur l’antigène de surface (AgHBs) chez des patients co-infectés VHB-VIH à AbidjanView Abstract
AbstractViral Hepatitis and Liver DiseaseCOLDA_2020_abstract_7_Hepatitis B Awareness and Perceptions Among Healthcare Workers Across Africa: Report From the African Hepatitis B NetworkView Abstract
AbstractViral Hepatitis and Liver DiseaseCOLDA_2020_abstract_9_Hepatocellular carcinoma in Senegal : epidemiological, clinical and etiological aspects about 229 cases at Hopital Principal de DakarView Abstract
AbstractViral Hepatitis and Liver DiseaseCOLDA_2020_abstract_8_DNA methyltransferases as potential biomarkers of HCV related hepatocellular carcinomaView Abstract
AbstractViral Hepatitis and Liver DiseaseCOLDA_2020_abstract_10_Propranolol reduces portal vein diameter in schistosomal liver disease with portal hypertension: a prospective cohort studyView Abstract
AbstractViral Hepatitis and Liver DiseaseCOLDA_2020_abstract_12_Prevalence of naturally occurring Resistance-Associated Variants to Hepatitis C Virus Direct-Acting Antiviral Agents in Treatment-Naive Patients in CameroonView Abstract
AbstractViral Hepatitis and Liver DiseaseCOLDA_2020_abstract_11_Seroprevalence and molecular epidemiology of hepatitis C in Malawi: A cross-sectional community census-based serological survey of Ndriande, BlantyreView Abstract
AbstractViral Hepatitis and Liver DiseaseCOLDA_2020_abstract_13_Hépatite virale C chronique : efficacité et tolérance des antiviraux à action directe au Centre Hospitalier Universitaire Yalgado OuédraogoView Abstract
AbstractViral Hepatitis and Liver DiseaseCOLDA_2020_abstract_15_Approach to community health education on hepatitis BView Abstract
AbstractViral Hepatitis and Liver DiseaseCOLDA_2020_abstract_14_Prevalence of Occult Hepatitis C Virus Infection among Egyptian Haemodialysis Patients: A Single Centre StudyView Abstract
AbstractViral Hepatitis and Liver DiseaseCOLDA_2020_abstract_16_HBV awareness and self-reported testing and vaccination in Ghanaian migrants living in the greater Barcelona area participating in a community-based interventionView Abstract
AbstractViral Hepatitis and Liver DiseaseCOLDA_2020_abstract_18_Seroprevalence and associated risk factors for Hepatitis B virus infection among barbers and their clients in two cities of CameroonView Abstract
AbstractViral Hepatitis and Liver DiseaseCOLDA_2020_abstract_17_Seroprevalence and risk factors for HCV in General population of Bauchi state, NigeriaView Abstract
AbstractViral Hepatitis and Liver DiseaseCOLDA_2020_abstract_19_Can Treatment for Hepatitis C Virus in Resource-Constrained Settings Improve Case Finding and Control of Highly Prevalent Chronic Co-Morbidities? Secondary Analysis from the SHARED Study in RwandaView Abstract
AbstractViral Hepatitis and Liver DiseaseCOLDA_2020_abstract_20_Evaluation of the analytical performance of six rapid diagnostic tests for the detection of viral hepatitis B and C in Lubumbashi, Democratic Republic of CongoView Abstract
AbstractViral Hepatitis and Liver DiseaseCOLDA_2020_abstract_21_Diagnostic Assessment of Hepatitis B Virus Serological and qPCR protocols among Infected Persons referred to an Abuja Suburb Tertiary Hospital, NigeriaView Abstract
AbstractViral Hepatitis and Liver DiseaseCOLDA_2020_abstract_22_Evidence of systemic responses to viral pathogens using malondialdehyde, tumor necrosis factor alpha and superoxide dismutaseView Abstract
AbstractViral Hepatitis and Liver DiseaseCOLDA_2020_abstract_23_Possible Expression of Viral seromarkers and inflammatory responses in patients with decreased plasma Superoxide dismutaseView Abstract
AbstractViral Hepatitis and Liver DiseaseCOLDA_2020_abstract_24_Comparison of the new Alinity m HBV with the CAP/CTM HBV for quantification of HBV in serum and plasmaView Abstract
AbstractViral Hepatitis and Liver DiseaseCOLDA_2020_abstract_25_Comparison of the new Alinity m HCV with the Abbott RealTime HCV for quantification of HCV in serum and plasmaView Abstract
AbstractViral Hepatitis and Liver DiseaseCOLDA_2020_abstract_26_Improved molecular laboratory workflow with test consolidation on the Alinity m SystemView Abstract
AbstractViral Hepatitis and Liver DiseaseCOLDA_2020_abstract_27_The role of unsafe medical practices and sexual behaviors in the hepatitis B and C syndemic and HIV co-infection in Rwanda: A cross sectional studyView Abstract
AbstractViral Hepatitis and Liver DiseaseCOLDA_2020_abstract_28_Sustainability of immune response to hepatitis b virus vaccination 3 years post vaccination among hiv-1 infected and uninfected adults in KenyaView Abstract
AbstractViral Hepatitis and Liver DiseaseCOLDA_2020_abstract_29_HBV and TB infections in HIV-infected Adults Initiating Truvada-based Combination Antiretroviral Therapy in Botswana.View Abstract
AbstractViral Hepatitis and Liver DiseaseCOLDA_2020_abstract_30_Low Genetic Diversity of Hepatitis B Virus Isolates from Human Immunodeficiency Virus infected population in NigeriaView Abstract
AbstractViral Hepatitis and Liver DiseaseCOLDA_2020_abstract_32_Clinical Features’ Frequency of Occult Hepatitis C Virus Infection (OCI) in People Living with HIV / AIDS at Yaoundé Central Hospital, CameroonView Abstract
AbstractViral Hepatitis and Liver DiseaseCOLDA_2020_abstract_33_Seroprevalence and viral load of HBV, HCV and HIV co infected patients on ART in Bauchi, NigeriaView Abstract
AbstractViral Hepatitis and Liver DiseaseCOLDA_2020_abstract_34_Séroprévalence de l’hépatite D chez les personnes atteintes d’hépatite B chronique à Lubumbashi (RDC)View Abstract
AbstractViral Hepatitis and Liver DiseaseCOLDA_2020_abstract_35_Hépatite virale B-Delta au Sénegal: aspects epidemiologiques, cliniques, paracliniques, therapeutiques et evolutifsView Abstract
AbstractViral Hepatitis and Liver DiseaseCOLDA_2020_abstract_36_Innate immune response in Plasmodium coinfection with HBV and HCV using complement C3, C4, and CD4+ T cellsView Abstract
AbstractViral Hepatitis and Liver DiseaseCOLDA_2020_abstract_38_High HIV Viremia is associated with Increased Risk of Liver Cancers among poorly Viral Suppressed ART Initiators in South Western NigeriaView Abstract
AbstractViral Hepatitis and Liver DiseaseCOLDA_2020_abstract_37_Prevalence de l’AgHBs et l’AcHCV chez les hemodialyses : cas de l’hopital general de Yaounde, CamerounView Abstract
AbstractViral Hepatitis and Liver DiseaseCOLDA_2020_abstract_40_Possible Role of Natural Killer Cells in Hepatitis C Virus Related Hepatocellular CarcinomaView Abstract
AbstractViral Hepatitis and Liver DiseaseCOLDA_2020_abstract_39_Outcomes of Sorafenib therapy for hepatocellular carcinoma in EthiopiaView Abstract
AbstractViral Hepatitis and Liver DiseaseCOLDA_2020_abstract_41_Risks of developing hepatocellular carcinoma in patients with chronic HCV-infectionView Abstract
AbstractViral Hepatitis and Liver DiseaseCOLDA_2020_abstract_42_Hepatic Resection for Hepatocelullar Carcinoma in Nigeria: a Sigle Centre Experiece from Northwest NigeriaView Abstract
AbstractViral Hepatitis and Liver DiseaseCOLDA_2020_abstract_43_Plasminogen Activator Inhibitor Type 1 in Liver Cirrhosis Patients and Non-Alcoholic Steatohepatitis under the Influence of Treatment with Human Albumin InfusionView Abstract
AbstractViral Hepatitis and Liver DiseaseCOLDA_2020_abstract_44_Clinical and laboratory predictors of mortality in patients hospitalized for liver cirrhosis in CameroonView Abstract
AbstractViral Hepatitis and Liver DiseaseCOLDA_2020_abstract_45_Devenir au long cours des patients traités par analogues nucléot(s)idiques pour cirrhose virale B à l’Hôpital Principal de DakarView Abstract
AbstractViral Hepatitis and Liver DiseaseCOLDA_2020_abstract_46_Correction of portohepatic hemodynamics disorders and increased ammonia by ornithine at the non-alcoholic steatohepatitis patients without cirrhosisView Abstract
AbstractViral Hepatitis and Liver DiseaseCOLDA_2020_abstract_47_Impact of Treating Hyperuricemic NAFLD Patients with Allopurinol on Cytokeratin 18: A Pilot StudyView Abstract
AbstractViral Hepatitis and Liver DiseaseCOLDA_2020_abstract_48_IL-23 and MMP-9 as predictors of adverse course of psoriasis and NAFLD comorbiditiesView Abstract
AbstractViral Hepatitis and Liver DiseaseCOLDA_2020_abstract_49_Les hépatites auto-immunes à l’Hôpital Principal de Dakar : étude rétrospective à propos de 19 cas.View Abstract
AbstractViral Hepatitis and Liver DiseaseCOLDA_2020_abstract_50_Hepatorenal Modulatory Effects of Ricinus Communis fractions in Acetaminophen-induced Hepatic-nephrotoxicity in Murine ModelView Abstract
AbstractViral Hepatitis and Liver DiseaseCOLDA_2020_abstract_51_Hepatitis C Elimination in Rwanda: The Case-Finding JourneyView Abstract
AbstractViral Hepatitis and Liver DiseaseCOLDA_2020_abstract_52_Rwanda’s journey to achieve low prices for Hepatitis C treatment drugsView Abstract
AbstractViral Hepatitis and Liver DiseaseCOLDA_2020_abstract_53_Prevalence of Hepatitis among Select Key Populations in Botswana – Results of the 2nd Biological and Behavioral Surveillance SurveyView Abstract
AbstractViral Hepatitis and Liver DiseaseCOLDA_2020_abstract_54_Risk of residual transmission of hepatitis B virus (HBV), hepatitis C virus (HCV) and human immunodeficiency virus (HIV) through blood transfusion in Burkina Faso: preliminary resultsView Abstract
AbstractViral Hepatitis and Liver DiseaseCOLDA_2020_abstract_55_Safety and efficacy of different direct-acting antiviral treatment regimens in hepatitis C infected patients with renal impairment: a single center experienceView Abstract
AbstractViral Hepatitis and Liver DiseaseCOLDA_2020_abstract_56_Assessment of protective serum anti-HBsAb levels among previously HBV vaccinated medical residents and its relation to duration and doses of vaccine – single center studyView Abstract
AbstractViral Hepatitis and Liver DiseaseCOLDA_2020_abstract_57_Infection chronique au virus de l’hépatite B (VHB) à antigène Hbe négatif au Sénégal : devenir des patients suivis à l’Hôpital Principal de DakarView Abstract
AbstractViral Hepatitis and Liver DiseaseCOLDA_2020_abstract_58_The Genedrive Assay Validation: A Point of Care Testing Device for Qualitative HCV RNA DetectionView Abstract
AbstractViral Hepatitis and Liver DiseaseCOLDA_2020_abstract_59_Epidemiology of Hepatitis B Virus Infection in Lubumbashi, Democratic Republic of Congo: Prevalence, risk factors and Genotype Distribution among Pregnant WomenView Abstract
AbstractViral Hepatitis and Liver DiseaseCOLDA_2020_abstract_60_Genotype distribution of hepatitis C virus: Experience in Maputo, MozambiqueView Abstract
AbstractViral Hepatitis and Liver DiseaseCOLDA_2020_abstract_61_Prevalence of Hepatitis B Virus and Vaccine Antibody Titers Among HIV Positive and Negative Infants in BotswanaView Abstract
AbstractViral Hepatitis and Liver DiseaseCOLDA_2020_abstract_62_Variceal Recurrence 4 years beyond Endoscopic Band Ligationin Hepatitis C Patients who Achieved Sustained Virological Response Post Direct Acting Antiviral Therapies.View Abstract
AbstractViral Hepatitis and Liver DiseaseCOLDA_2020_abstract_63_Feasibility of the Public Health Approach in the Management of Hepatitis C Virus (HCV) in Nigeria, using the Pangenotypic Direct Acting Antiviral (DAAs)View Abstract
AbstractViral Hepatitis and Liver DiseaseCOLDA_2020_abstract_64_Aetiology and outcomes of cirrhosis and hepatocellular carcinoma (HCC) in Queen Elizabeth Central Hospital (QECH), Blantyre, MalawiView Abstract
AbstractViral Hepatitis and Liver DiseaseCOLDA_2020_abstract_66_Evaluation of the Efficacy of the Egyptian Program for Hepatitis B Virus Vaccination: A Cross Sectional National SurveyView Abstract
AbstractViral Hepatitis and Liver DiseaseCOLDA_2020_abstract_65_L’hépatite virale B chronique chez les patients porteurs de l’antigène HBe : aspects diagnostiques, thérapeutiques et évolutifs.View Abstract
AbstractViral Hepatitis and Liver DiseaseCOLDA_2020_abstract_67_Performance of hepatitis B e antigen (HBeAg) rapid diagnostic tests (RDTs) in Malawi: A comparative evaluation in community and inpatient populations with hepatitis B virus (HBV)View Abstract
AbstractViral Hepatitis and Liver DiseaseCOLDA_2020_abstract_68_Prevalence of hepatocellular carcinoma in Chronic Hepatitis B Genotype E African patients – a single centre experienceView Abstract
AbstractViral Hepatitis and Liver DiseaseCOLDA_2020_abstract_69_Assessment of Non-invasive Markers of Liver Fibrosis in Patients with Hepatitis C Virus in EthiopiaView Abstract
AbstractViral Hepatitis and Liver DiseaseCOLDA_2020_abstract_70_Identifying Gaps Across the Cascade of Care for the Prevention of HBV Mother-To-Child Transmission in Burkina Faso: Findings from the Real WorldView Abstract
AbstractViral Hepatitis and Liver DiseaseCOLDA_2020_abstract_71_Awareness of Preventive Measures Against Hepatitis B Infection Among Pregnant Women Attending a Tertiary Health Facility in Osun State, NigeriaView Abstract
AbstractViral Hepatitis and Liver DiseaseCOLDA_2020_abstract_72_Évaluation de l'état des Connaissances sur l'hépatite Virale B des Patients en Consultation d'hépato-Gastroentérologie à l'hôpital General Idrissa Pouye (Dakar, Senegal)View Abstract
AbstractViral Hepatitis and Liver DiseaseCOLDA_2020_abstract_73_Profil Epidemiologique Diagnostique et Therapeutique des Patients Porteurs du Virus de l’hepatite C: À Propos de 26 CasView Abstract
AbstractViral Hepatitis and Liver DiseaseCOLDA_2020_abstract_74_Assessment of Hepatitis B Virus Infection and Associated Factors Among Pregnant Women Attending Antenatal Care Service in Bishoftu Town, South East EthiopiaView Abstract
AbstractViral Hepatitis and Liver DiseaseCOLDA_2020_abstract_75_Modeling Viral Hepatitis B and C Status in Taraba State Using Logistic RegressionView Abstract
AbstractViral Hepatitis and Liver DiseaseCOLDA_2020_abstract_76_Epidemiological Profile of Hepatitis B Cases in Baringo County, KENYA, 2018View Abstract
AbstractViral Hepatitis and Liver DiseaseCOLDA_2020_abstract_78_Risk of Liver Disease among Blood Donors Infected with Hepatitis C VirusView Abstract
AbstractViral Hepatitis and Liver DiseaseCOLDA_2020_abstract_77_Marqueurs Biologiques de l'hépatite Virale B A l’initiation du Traitement Antiviral en Ambulatoire au Service des Maladies Infectieuses du Chu du Point G, Bamako, MaliView Abstract
